Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Acq. announced
Appointed director

Phio Pharmaceuticals Corp. (RXII) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/03/2023 4 Bitterman Robert J (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Paid exercise price by delivering 917 shares @ $1.51, valued at $1.4k
07/05/2023 4 Bitterman Robert J (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Bought 1,000 shares @ $2.88, valued at $2.9k
Bought 1,000 shares @ $2.84, valued at $2.8k
06/15/2023 4 Ferrara Robert L (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Bought 2,000 shares @ $3.1, valued at $6.2k
02/22/2023 4 Lockshin Curtis (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 1,500 shares @ $0
02/22/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2023 4 CAUWENBERGH GEERT (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 1,500 shares @ $0
02/22/2023 4 BRADFORD PATRICIA A (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 1,500 shares @ $0
02/22/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/22/2023 4 Bitterman Robert J (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 11,000 shares @ $0
12/15/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/08/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/06/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/05/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/29/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/28/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/16/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/03/2022 4 Bitterman Robert J (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 40,000 shares @ $0
09/26/2022 4 BRADFORD PATRICIA A (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 20,000 shares @ $0
04/29/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
03/03/2022 4 Kontulis Caitlin (Secretary & VP Finance & Admin) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Paid exercise price by delivering 4,011 shares @ $0.821, valued at $3.3k
03/03/2022 4 Dispersyn Gerrit (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Paid exercise price by delivering 8,954 shares @ $0.821, valued at $7.4k
02/16/2022 4 Lockshin Curtis (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 10,000 shares @ $0
02/16/2022 4 Kontulis Caitlin (Secretary & VP Finance & Admin) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 68,000 shares @ $0
02/16/2022 4 Freeman Jonathan E (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 10,000 shares @ $0
02/16/2022 4 Ferrara Robert L (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 10,000 shares @ $0
02/16/2022 4 Dorman H. Paul (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 10,000 shares @ $0
02/16/2022 4 Dispersyn Gerrit (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 126,000 shares @ $0
02/16/2022 4 CAUWENBERGH GEERT (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 10,000 shares @ $0
02/16/2022 4 Bitterman Robert J (Director) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Granted 10,000 shares @ $0
08/17/2021 4 Dispersyn Gerrit (President & CEO) has filed a Form 4 on Phio Pharmaceuticals Corp.
Txns: Bought 6,000 shares @ $1.63, valued at $9.8k
03/05/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy